Login / Register for free to get access to My MedWorm

Query: "risk management"Query: This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. subscribe with MyMedWormSubscribe to this data using MyMedWorm.subscribe with GoogleReaderSubscribe to this data using GoogleReader.subscribe with BloglinesSubscribe to this data using Bloglines.

This page shows you your search results in order of date.

1330 records returned

DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategiesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The Drug Information (DIA) will host its 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies from January 10-13, 2010 in Washington, DC. (PRWeb Nov 19, 2009) Read the full story at http://www.prweb.com/releases/DIA/Safety_Conference/prweb3230364.htm
Source: PRWeb: Medical Pharmaceuticals - November 20, 2009 Category: Pharmaceuticals Source Type: news

Pharmacovigilanceemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The importance of developing effective pharmacovigilance systems has been fuelled by an increased focus on drug safety and the ever-changing regulatory environment. This conference will tackle inspections, risk management, the use of Independent Data Monitoring Committees and establishing relationships with regulatory bodies along with a host of other key topics. Reasons to Attend • Hear the latest updates on various pharmacovigilance systems in the industry • Explore ways in which you can optimise your own pharmacovigilance activities • Discuss the potential impact of impending regulatory changes • Network with...
Source: Nature Network London - Upcoming Events - November 18, 2009 Category: Science Source Type: events

BioSoteria CEO to Present at Drug Safety Conferenceemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
BioSoteria announced that its President and CEO Sally Van Doren, PharmD, will present at the 9th DIA Conference for Contemporary Pharmacovigilance and Risk Management Strategies, which takes place January 10-13, 2010, in Washington, DC. Dr. Van Doren will present on the topic of the Integrated Summary of Safety. (PRWeb Nov 18, 2009) Read the full story at http://www.prweb.com/releases/pharmacovigilance/conference/prweb3225234.htm
Source: PRWeb: Medical Pharmaceuticals - November 18, 2009 Category: Pharmaceuticals Source Type: news

Evaluation of Post-Authorization Safety Studies in the First Cohort of EU Risk Management Plans at Time of Regulatory Approvalemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Source: Drug Safety - November 18, 2009 Category: Drugs & Pharmacology Authors: Giezen, Thijs J.Mantel-Teeuwisse, Aukje K.Straus, Sabine M.J.M.Egberts, Toine C.G.Blackburn, StellaPersson, IngemarLeufkens, Hubert G.M. Tags: Original Research Articles Source Type: journals

Laboratory Tests in the Clinical Risk Management of Potential Drug-Drug Interactions: A Cross-Sectional Study Using Drug-Dispensing Data from 100 Dutch Community Pharmaciesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Source: Drug Safety - November 18, 2009 Category: Drugs & Pharmacology Authors: Geerts, Arjen F.J.De Koning, Fred H.P.De Smet, Peter A.G.M.Van Solinge, Wouter W.Egberts, Toine C.G. Tags: Original Research Articles Source Type: journals

Commentary: Primary prevention of cardiovascular diseaseemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Source: JAMA Area: News In this commentary, the author discusses different approaches to the primary prevention of cardiovascular disease (CVD), now that the cost of statins has decreased and there is a large amount of data available on their efficacy and safety.  They ask whether "for an inexpensive treatment, known to be safe and effective, should the eligibility be widened?" They also ask what the consequences of the new vascular checks - a 'systematic risk-based approach' - are, and how they compare with alternatives.    They conclude that "scant information is available on the cost and the public a...
Source: NeLM - News - November 18, 2009 Category: Drugs & Pharmacology Source Type: organizations

Risk management: create a culture of safetyemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The best approach to risk management is to establish a safety culture throughout your organisation, say Peter Mills and colleagues
Source: HSJ - November 17, 2009 Category: UK Health Source Type: info

Role of Wild Suids in the Epidemiology of African Swine Feveremail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Abstract  There is presently no vaccine to combat African swine fever (ASF), a viral hemorrhagic fever of domestic pigs that causes up to 100% morbidity and mortality in naive, commercial pig populations. In its endemic setting, ASF virus cycles between asymptomatic warthogs and soft ticks, with persistence in exotic locations being ascribed to the almost global distribution of susceptible soft tick and suid hosts. An understanding of the role played by diverse hosts in the epidemiology of this multi-host disease is crucial for effective disease control. Unlike the intensively studied Ornithodoros tick vector...
Source: EcoHealth - November 14, 2009 Category: Environmental Health Tags: EcoHealth Source Type: journals

A study of the shielding used to reduce leakage and scattered radiation to the fetus in a pregnant patient treated with a 6-mv external x-ray beam.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
A Monte Carlo-based procedure has been developed to assess the shielded fetal doses from 6 MV external photon beam radiation treatments and improve upon existing techniques that are based on AAPM Task Group Report 36 (TG-36). Anatomically realistic models of the pregnant patient representing 3- and 6-mo gestational stages were implemented into the MCNPX code together with a detailed accelerator model that is capable of simulating scattered and leakage radiation from the accelerator head. The phantom was shielded using suggested lead and Cerrobend in different locations and with different thicknesses. Absorbed doses to ...
Source: Health Physics - November 12, 2009 Category: Physics Authors: Han B, Bednarz B, Xu XG Tags: Health Phys Source Type: journals

Role of darunavir in the management of HIV infectionemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
R Monica Lascar, Paul Benn
Source: Therapeutics and Clinical Risk Management - November 10, 2009 Category: Drugs & Pharmacology Source Type: journals

Risk assessment of carcinogens in food.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Approaches for the risk assessment of carcinogens in food have evolved as scientific knowledge has advanced. Early methods allowed little more than hazard identification and an indication of carcinogenic potency. Evaluation of the modes of action of carcinogens and their broad division into genotoxic and epigenetic (non-genotoxic, non-DNA reactive) carcinogens have played an increasing role in determining the approach followed and provide possibilities for more detailed risk characterisation, including provision of quantitative estimates of risk. Reliance on experimental animal data for the majority of risk assessments...
Source: Toxicology and Applied Pharmacology - November 9, 2009 Category: Toxicology Authors: Barlow S, Schlatter J Tags: Toxicol Appl Pharmacol Source Type: journals

DIA Conference to Explore Components of Risk Management Plans As They Apply to Medicinal Products, Therapeutic Biologics and Vaccinesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Expert speakers from industry, Health Canada, EMEA, FDA, and PMDA will lead presentations at the 2nd DIA Conference on Harmonization of Risk Management Plans to be held December 10-11, 2009 in Washington, DC. (PRWeb Nov 6, 2009) Read the full story at http://www.prweb.com/releases/2009/11/prweb3163264.htm
Source: PRWeb: Medical Pharmaceuticals - November 6, 2009 Category: Pharmaceuticals Source Type: news

Safety profile of Tysabri: international risk management planemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Abstract  Therapeutic monoclonal antibodies are potent new tools for a molecular targeted approach to modify the course of multiple sclerosis (MS). Natalizumab is a monoclonal antibody targeted against alpha-4 integrin that has proved to be very effective in the treatment of MS. It is well tolerated, although severe side effects have been reported that have conditioned its use as a second-line drug for the treatment of MS. The clinical benefit of natalizumab should be weighed carefully against the potential risk of serious adverse events. Therefore, risk management plans have already been developed in order t...
Source: Neurological Sciences - November 3, 2009 Category: Neurology Tags: Neurological Sciences Source Type: journals

Use of videophone technology to address medication adherence issues in persons with HIVemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Michael J Skrajner, Cameron J Camp, Jessica L Haberman, et al.
Source: Therapeutics and Clinical Risk Management - November 2, 2009 Category: Drugs & Pharmacology Source Type: journals

Risk management standards in midwifery are no substitute for personal knowledge and accountability.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Integration of complementary therapies in maternity practice is an ever growing field. Midwives have burgeoning interest in and are increasingly using complementary therapies within their practice. Issues regarding knowledge and safety remain essential within midwifery care. It is possible that the use of complementary therapies during pregnancy is not always based on a foundation of adequate knowledge and therefore may not be completely safe. Risk management is essential, both within conventional maternity care and where there is integration of new practices, to ensure that client safety is paramount. In order for int...
Source: Complementary Therapies in Clinical Practice - November 1, 2009 Category: Complementary Medicine Authors: Kenyon C Tags: Complement Ther Clin Pract Source Type: journals

Ustekinumab Approved With Safety Requirementemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The Food and Drug Administration's approval of ustekinumab for moderate to severe plaque psoriasis—the first interleukin-12 and −23 antagonist to be approved in the United States—is accompanied by requirements for a risk management plan and postmarketing studies that address uncertainties about the long-term safety of the biologic drug.
Source: Skin and Allergy News - November 1, 2009 Category: Dermatology Authors: ELIZABETH MECHCATIE Tags: News Source Type: journals

Novel biomarkers of acute kidney toxicity.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Novel biomarkers of kidney toxicity are powerful tools not only with respect to their clinical applications but also because of their impact on drug development. These biomarkers can influence the assessment of efficacy of new drugs for kidney diseases as well as the risk management for new drugs. The science behind these novel biomarkers reflects the evolution over the past decade of genomic and proteomic platforms that have transformed the discovery and development of new biomarkers for preclinical and clinical applications in drug development. Several of these biomarkers are in use as transcriptomic biomarkers in an...
Source: Clinical Pharmacology and Therapeutics - November 1, 2009 Category: Drugs & Pharmacology Authors: Goodsaid FM, Blank M, Dieterle F, Harlow P, Hausner E, Sistare F, Thompson A, Vonderscher J Tags: Clin Pharmacol Ther Source Type: journals

Tips for Curbing Malpractice Insurance Costsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
CORONADO, CALIF. — As general counsel and director of risk management for Canton, Ohio–based Emergency Medicine Physicians, Dr. Michael Frank fields his share of calls from partner groups asking for insight on how to keep a lid on malpractice insurance costs.
Source: Internal Medicine News - November 1, 2009 Category: Internal Medicine Authors: DOUG BRUNK Tags: Practice Trends Source Type: journals

Population mobility, globalization, and antimicrobial drug resistance.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Population mobility is a main factor in globalization of public health threats and risks, specifically distribution of antimicrobial drug-resistant organisms. Drug resistance is a major risk in healthcare settings and is emerging as a problem in community-acquired infections. Traditional health policy approaches have focused on diseases of global public health significance such as tuberculosis, yellow fever, and cholera; however, new diseases and resistant organisms challenge existing approaches. Clinical implications and health policy challenges associated with movement of persons across barriers permeable to products...
Source: Emerging Infectious Diseases - November 1, 2009 Category: Infectious Diseases Authors: MacPherson DW, Gushulak BD, Baine WB, Bala S, Gubbins PO, Holtom P, Segarra-Newnham M Tags: Emerg Infect Dis Source Type: journals

Pandemic preparedness - Risk management and infection control for all respiratory infection outbreaks.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
DISCUSSION: Pandemic planning and preparedness in general practice is ultimately a crucial risk management exercise, the cornerstone of which is sound infection control. As planning will be significantly aided by, and should extend to, other respiratory outbreaks, we propose a framework for managing outbreaks of respiratory infections with a focus on planned, practised and habitual infection control measures, and a stepwise response according to the extent and severity of the outbreak. PMID: 19893837 [PubMed - in process]
Source: Australian Family Physician - November 1, 2009 Category: Primary Care Authors: Nori A, Williams MA Tags: Aust Fam Physician Source Type: journals

REMS for Extended-Release Opioid Under Reviewemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
GAITHERSBURG, MD. — A federal advisory panel supported the risk management plan proposed by the manufacturer of an extended-release formulation of hydromorphone, which is not yet approved for marketing in the United States. The plan is intended to minimize overdoses, abuse, and diversion of the opioid.
Source: Rheumatology News - November 1, 2009 Category: Rheumatology Authors: ELIZABETH MECHCATIE Tags: News from the FDA Source Type: journals

First IL-12 and −23 Blocker Approved for Psoriasis, With Safety Requirementsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The Food and Drug Administration's approval of ustekinumab for moderate to severe plaque psoriasis—the first interleukin-12 and −23 antagonist to be approved in the United States—is accompanied by requirements for a risk management plan and postmarketing studies that address uncertainties about the long-term safety of the biologic.
Source: Rheumatology News - November 1, 2009 Category: Rheumatology Authors: ELIZABETH MECHCATIE Tags: News from the FDA Source Type: journals

Safety and Risk Management Interventions in Hospitals: A Systematic Review of the Literatureemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The aim of this systematic review was (a) to synthesize the evidence on the effectiveness of detection, mitigation, and actions to reduce risks in hospitals and (b) to identify and describe components of interventions responsible for effectiveness. Thirteen literature databases were explored using a structured search and data extraction strategy. All included studies dealing with incident reporting described positive effects. Evidence regarding the effectiveness and efficiency of safety analysis is scarce. No studies on mitigation were included. The collected evidence on risk reduction concerns a variety of interventions t...
Source: Medical Care Research and Review - October 30, 2009 Category: Health Management Authors: Duckers, M., Faber, M., Cruijsberg, J., Grol, R., Schoonhoven, L., Wensing, M. Tags: Articles Source Type: journals

Informed decision making about predictive DNA tests: arguments for more public visibility of personal deliberations about the good lifeemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Abstract  Since its advent, predictive DNA testing has been perceived as a technology that may have considerable impact on the quality of people’s life. The decision whether or not to use this technology is up to the individual client. However, to enable well considered decision making both the negative as well as the positive freedom of the individual should be supported. In this paper, we argue that current professional and public discourse on predictive DNA-testing is lacking when it comes to supporting positive freedom, because it is usually framed in terms of risk and risk management. We show how this ...
Source: Medicine, Health Care and Philosophy - October 30, 2009 Category: Medical Ethics Tags: Medicine, Health Care and Philosophy Source Type: journals

Risk Mitigation and Its Impact on Pharma Marketingemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
This article summarizes ParagonRx's ideas about how to develop a REMS that can be a win-win-win situation for you, your product, and the patient.
Source: Pharma Marketing News - October 29, 2009 Category: Pharmaceuticals Source Type: info

Zoning: focused support: a trust wide implementation projectemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Applying pragmatic risk management procedures to facilitate the sharing of clinical knowledge in and across mental health teams. Zoning: focused support is pragmatic risk management support procedure that enhances adherence to operational policies, provides a forum in which staff can receive support and visually facilitates the sharing of clinical knowledge. This paper presents a 3-year multi-method management project that sought to introduce zoning principles into all teams of an inner city Mental Health NHS Trust. By changing the language and culture of the organization findings indicate that there has been a positive at...
Source: Journal of Psychiatric and Mental Health Nursing - October 29, 2009 Category: Nursing Authors: C. GAMBLE, G. DODD, J. GRELLIER, M. HEVER, C. O'CONNER, T. CLARKE, R. CHIPERE, M. MELLOR, M. NESS Source Type: journals

Paediatric Clinical Trialsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
SMi are proud to present their 4th annual Paediatric Clinical Trials conference. This year’s event will explore the latest developments in legislation introduced by the EMEA along with a variety of issues relating to trial design. By attending you will gain valuable insights into the evolving regulatory framework for paediatric trials and have an unrivalled opportunity to network with industry associates Topics at this year’s event include: How to address the paediatric population in drug evaluation Clinical development and risk management in the post-approval phase Ethical considerations in paediatric clinical trials ...
Source: Nature Network London - Upcoming Events - October 27, 2009 Category: Science Source Type: events

The knowns and unknowns of human milk bankingemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Abstract: The PREM Bank has been providing pasteurised donor human milk (PDHM) to very preterm for the past 3 years. It is the first human milk bank (HMB) to operate in Australia in over 20 years. Our community has rapidly embraced the concept of human milk banking, with both donations and demand for PDHM exceeding expectations. Providing PDHM in ‘exceptional circumstances’ where a mothers’ own milk is unavailable is supported by the WHO and UNICEF. We submit that neonatal intensive care is an exceptional circumstance. Although evidence supporting PDHM use from randomised control trial (RCT) is limited, the latest ...
Source: Early Human Development - October 23, 2009 Category: Perinatology & Neonatology Authors: Karen Simmer, Ben Hartmann Tags: Guest Editor N. Modi Source Type: journals

GPC urges PCOs to cover cost of maternity payemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Risk management of the potential cost of salaried GP maternity pay should fall on primary care organisations (PCOs) rather than practices, the GPC has said.
Source: HealthcareRepublic Independent Nurse News - October 23, 2009 Category: Nursing Source Type: news

Safe drinking water: Critical components of effective inter-agency relationships.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The paper supports the development of evidence-based emergency management frameworks of cooperation between agencies in the area of drinking water and public health, as part of developing the overall risk management culture within water utilities. We employed a qualitative research design to understand critical gaps in inter-agency relations that aggravated past drinking water and health incidents and from these identified determinants of effective relationships. We identified six critical institutional relationship components that were deficient in past incidents, namely proactivity, communication, training, sharing e...
Source: Environment International - October 23, 2009 Category: Environmental Health Authors: Jalba DI, Cromar NJ, Pollard SJ, Charrois JW, Bradshaw R, Hrudey SE Tags: Environ Int Source Type: journals

Ethics-based training for nonclinical staff in mental health settings.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Under the Ethics Code of the American Psychological Association (2002), psychologists are responsible for ensuring that delegated tasks are performed competently. For staff members who interact with clients or who have access to confidential client information, technical competence may not suffice. Psychologists who want to provide the best protection for clients can offer staff training that fosters “ethical competence” as well. Setting-specific ethics training is important even for personnel who have previously worked in other mental health sites, because it demonstrates how the profession’s ethical standards will ...
Source: Professional Psychology: Research and Practice - October 20, 2009 Category: Psychiatry & Psychology Authors: Fisher, Mary Alice Source Type: journals

Does Advice from Pharmacy Staff Vary According to the Nonprescription Medicine Requested? (November).email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
CONCLUSIONS: Emerging patterns imply that pharmacy staff response may vary according to the medicine requested. It may be that pharmacists and their staff prioritize drugs or behaviors that they consider critically relevant as part of a risk management approach. This has possible implications for future scheduling policy. Further research using a range of scenarios would more fully explore the breadth of such behavior. This would aid identification of medicines that trigger professional intervention and inform development of targeted training programs. PMID: 19843841 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - October 19, 2009 Category: Drugs & Pharmacology Authors: Kelly FS, Williams KA, Benrimoj SI Tags: Ann Pharmacother Source Type: journals

Documentation Quality in Community Pharmacy: Completeness of Electronic Patient Records After Patients' First Visits(November).email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
CONCLUSIONS: The EPR after a patient's first visit to the community pharmacy is often incomplete. For new patients, the pharmacist should more proactively and systematically gather patient information, and all relevant information should be recorded, preferably in coded form, in the pharmacy information system to allow more adequate clinical risk management. PMID: 19843832 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - October 19, 2009 Category: Drugs & Pharmacology Authors: Floor-Schreudering A, De Smet PA, Buurma H, Egberts AC, Bouvy ML Tags: Ann Pharmacother Source Type: journals

Community-based intervention to optimise falls risk management: a randomised controlled trialemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Conclusions: compared to usual care, a multi-faceted intervention increased referrals to physiotherapy and occupational therapy but did not reduce risk of falls. Similar falls reduction interventions cannot be recommended based on the results of this study.
Source: Age and Ageing - October 19, 2009 Category: Geriatrics Authors: Ciaschini, P.M., Straus, S.E., Dolovich, L.R., Goeree, R.A., Leung, K.M., Woods, C.R., Zimmerman, G.M., Majumdar, S.R., Spadafora, S., Fera, L.A., Lee, H.N. Tags: Research Paper Source Type: journals

Pilot study of a fall risk management program for middle aged and older adults with MS. - Finlayson M, Peterson EW, Cho C.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Objective: To present the outcomes of a pilot study of "Safe at Home BAASE", a fall risk management program designed for middle-aged and older adults with multiple sclerosis. Methods: Thirty people with multiple sclerosis (mean age=56.7 +/- 7.4) started th...
Source: SafetyLit: All (Unduplicated) - October 18, 2009 Category: Global & Universal Tags: Age: Elder Adults Source Type: info

Treating violence: a guide to risk management in mental health violence risk assessment and management. - Coffey M.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
[Abstract unavailable] Language: Eng...
Source: SafetyLit: All (Unduplicated) - October 18, 2009 Category: Global & Universal Tags: Violence and Weapons Issues Source Type: info

InSight Health Solutions taps new VPemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Risk management software developer InSight Health Solutions of East Providence, RI, has appointed a new vice president of sales and marketing.
Source: AuntMinnie.com Headlines - October 15, 2009 Category: Radiology Source Type: info

Panel Backs Extended-Release Opioid's Risk Planemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
GAITHERSBURG, MD. — A federal advisory panel supported the risk management plan proposed by the manufacturer of an extended-release formulation of hydromorphone, which is not yet approved for marketing in the United States. The plan is intended to minimize overdoses, abuse, and diversion of the opioid
Source: Family Practice News - October 15, 2009 Category: Primary Care Authors: ELIZABETH MECHCATIE Tags: News from the FDA Source Type: news

Psychiatry Morbidity and Mortality Rounds: Implementation and Impact [RESEARCH ARTICLES]email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
CONCLUSION: M&Ms appear to be a potentially productive venue for self-appraisal and case review to aid psychiatry programs in patient safety efforts and clinician education.
Source: Acad Psychiatry - October 14, 2009 Category: Psychiatry Authors: Goldman, S., Demaso, D. R., Kemler, B. Tags: RESEARCH ARTICLES Source Type: journals

The ACEP Interviews: Michael Frank with Mark Plasteremail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Mark Plaster interviews Michael Frank, general counsel for Emergency Medicine Physicians, on risk management and liability reform Check back...
Source: EPMonthly.com - October 14, 2009 Category: Emergency Medicine Source Type: info

Leaving against medical advice: Facing the issue in the emergency departmentemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
This article attempts to mitigate these risks by reviewing what we know about AMA encounters from the ED and providing documentation guidelines for the encounter.
Source: Journal of Healthcare Risk Management - October 13, 2009 Category: Hospital Management Authors: Edward P. Monico, Ian Schwartz Tags: Claims & amp; Litigation Source Type: journals

Communication and documentation considerations for electronic health recordsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Electronic health records (EHRs) are here to stay, and their use is expected to grow significantly in the future. It is incumbent on risk managers to ensure their use does not inhibit good provider-to-patient communication. Providing education and strategies on how to make the patient encounter meaningful while the provider uses an EHR may increase patient satisfaction and may contribute to a favorable professional liability loss experience. Risk managers also need to have an understanding of the capabilities of each specific EHR system in the facility, the implications of the ability to cut-and-paste information from one ...
Source: Journal of Healthcare Risk Management - October 13, 2009 Category: Hospital Management Authors: Ann D. Gaffey Tags: Enterprise risk management Source Type: journals

Troublesome times demand more effective practicesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The intensifying financial pressures bearing down on the American government and taxpayers due to egregious corporate mismanagement will focus increasing and unprecedented scrutiny on the business world. The risk management community believes a paradigm shift is at hand. Organizations of every kind will feel pressure to do more than they have in the past to understand the risks they face, expose and challenge every assumption they make, and take steps to quantify and appropriately mitigate the exposures they identify. This will not be an easy transition. Just as the healthcare community has struggled over the past 25 years...
Source: Journal of Healthcare Risk Management - October 13, 2009 Category: Hospital Management Authors: Mary Botkin, Ken Felton Tags: Enterprise risk management Source Type: journals

Reuse of single-use devices: Protecting your reprocessing programemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
High-profile hepatitis C outbreaks in 2008 spurred the Centers for Disease Control and Prevention's attention toward legislative and regulatory action in several states around the practice of reuse of single-use devices. Promulgated in the interest of public safety, some of these new regulations and laws can have a potential impact on hospitals' ability to access third-party reprocessing duly regulated by the Food and Drug Administration.
Source: Journal of Healthcare Risk Management - October 13, 2009 Category: Hospital Management Authors: Lory Olsson Tags: Patient Safety Source Type: journals

Plaintiff in EMTALA claim need not be the injured patientemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No Abstract.
Source: Journal of Healthcare Risk Management - October 13, 2009 Category: Hospital Management Authors: John C. West Tags: Case Law Update Source Type: journals

Applying fighter pilot methodology to healthcareemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No Abstract.
Source: Journal of Healthcare Risk Management - October 13, 2009 Category: Hospital Management Authors: Kathy Rapala Tags: Reviews Source Type: journals

Documenting healthcare's journey through the patient safety landscapeemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No Abstract.
Source: Journal of Healthcare Risk Management - October 13, 2009 Category: Hospital Management Authors: Pamela L. Popp Tags: Reviews Source Type: journals

What is important to know about being a good witness?email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
No Abstract.
Source: Journal of Healthcare Risk Management - October 13, 2009 Category: Hospital Management Authors: Linda E. Hines Tags: Reviews Source Type: journals

Risk Management Policy and Black-Box Warnings: A Qualitative Analysis of US FDA Proceedingsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Source: Drug Safety - October 13, 2009 Category: Drugs & Pharmacology Authors: Cook, Daniel M.Gurugubelli, Rama K.Bero, Lisa A. Tags: Original Research Articles Source Type: journals

Lifetime cumulative exposure as a threat for neurodegeneration: need for prevention strategies on a global scale.email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Exposure to neurotoxic agents represents a concern of high priority in modern society. The nervous system can compensate for the toxic effects caused by low doses, but prolonged and lifetime exposure can also lead to delayed neurodegenerative effects for very low levels. The reported frequency of neurodegenerative diseases is constantly increasing, which results in serious negative impacts on the health of the population worldwide. Future estimates indicate that Parkinson's Disease will increase mostly in industrialized countries during the next few years. Exposure to neurotoxic agents can take place during the various...
Source: Neurotoxicology - October 12, 2009 Category: Neurology Authors: Lucchini R, Zimmerman N Tags: Neurotoxicology Source Type: journals